Literature DB >> 8265661

Allele-specific peptide ligand motifs of HLA-C molecules.

K Falk1, O Rötzschke, B Grahovac, D Schendel, S Stevanović, V Gnau, G Jung, J L Strominger, H G Rammensee.   

Abstract

The consensus motifs of HLA-Cw3, -Cw4, -Cw6, and -Cw7 ligands were determined by pool sequencing. Together with information obtained by sequencing of some prominent individual peptides, the results indicate the following: (i) all four HLA-C molecules are associated with peptides. (ii) These peptides adhere to allele-specific motifs that are similar to those of to HLA-A or -B molecules; they have a preferred length of nine amino acids and an anchor residue at the C terminus. (iii) All four HLA-C molecules analyzed exhibit related peptide motifs, although each allelic product shows individual characteristics in fine specificity. (iv) Processing and origin of peptides appear not to be different from that of other class I molecules. (v) No obvious difference at C-terminal position 9 was present in the peptides isolated from the two dimorphic variants of HLA-C that determine dominant resistance to natural killer NK1-specific cells (HLA-Cw4, -Cw6) or to NK2-specific cells (HLA-Cw3, -Cw7) and that differ in two residues in or near the pocket at position 9.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265661      PMCID: PMC48114          DOI: 10.1073/pnas.90.24.12005

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  HLA-JY328: mapping studies and expression of a polymorphic HLA class I gene.

Authors:  B W Duceman; D Ness; R Rende; M J Chorney; R Srivastava; D S Greenspan; J Pan; S M Weissman; F C Grumet
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Selection of highly transfectable variant from mouse mastocytoma P815.

Authors:  A Van Pel; E De Plaen; T Boon
Journal:  Somat Cell Mol Genet       Date:  1985-09

3.  H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide.

Authors:  J L Maryanski; P Pala; G Corradin; B R Jordan; J C Cerottini
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

Review 4.  Peptides naturally presented by MHC class I molecules.

Authors:  H G Rammensee; K Falk; O Rötzschke
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.

Authors:  O Rötzschke; K Falk; S Stevanović; B Grahovac; M J Soloski; G Jung; H G Rammensee
Journal:  Nature       Date:  1993-02-18       Impact factor: 49.962

6.  Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

Authors:  P Parham; F M Brodsky
Journal:  Hum Immunol       Date:  1981-12       Impact factor: 2.850

7.  Cell mediated lympholysis in man. The impact of HLA-C antigens.

Authors:  N Grunnet; T Kristensen; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1976-05

8.  Increased frequency of HLA-Cw4 in type 2 diabetes.

Authors:  L Groop; S Koskimies; R Pelkonen; E M Tolppanen
Journal:  Acta Endocrinol (Copenh)       Date:  1983-12

9.  Clones of human cytotoxic T lymphocytes derived from an allosensitized individual: HLA specificity and cell surface markers.

Authors:  B Malissen; T Kristensen; C Goridis; M Madsen; C Mawas
Journal:  Scand J Immunol       Date:  1981-09       Impact factor: 3.487

10.  HLA C associations with acute leukaemia.

Authors:  J D'Amaro; F H Bach; J J Van Rood; A A Rimm; M M Bortin
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

View more
  45 in total

1.  Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

Authors:  S Gnjatic; Y Nagata; E Jager; E Stockert; S Shankara; B L Roberts; G P Mazzara; S Y Lee; P R Dunbar; B Dupont; V Cerundolo; G Ritter; Y T Chen; A Knuth; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Large-scale analysis of HLA peptides presented by HLA-Cw4.

Authors:  Samuel Buchsbaum; Eilon Barnea; Lior Dassau; Ilan Beer; Elena Milner; Arie Admon
Journal:  Immunogenetics       Date:  2003-05-16       Impact factor: 2.846

3.  Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries.

Authors:  Sara O Dionne; Douglas F Lake; William J Grimes; Margaret H Smith
Journal:  Immunogenetics       Date:  2004-08-12       Impact factor: 2.846

4.  Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.

Authors:  R Maier; K Falk; O Rötzschke; B Maier; V Gnau; S Stevanović; G Jung; H G Rammensee; A Meyerhans
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.

Authors:  S Pepperl; G Benninger-Döring; S Modrow; H Wolf; W Jilg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 6.  HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?

Authors:  Marie-Eve Blais; Tao Dong; Sarah Rowland-Jones
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

Review 7.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 8.  Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.

Authors:  Ângela C Crespo; Anita van der Zwan; João Ramalho-Santos; Jack L Strominger; Tamara Tilburgs
Journal:  J Reprod Immunol       Date:  2016-08-02       Impact factor: 4.054

9.  Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.

Authors:  B Wizel; R A Houghten; K C Parker; J E Coligan; P Church; D M Gordon; W R Ballou; S L Hoffman
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.